Synthesis of 1, 3-dimethyl-8-(quinuclid-3 1-yl) xanthine and its investigation
GP Zhichareva, LN Yakhontov, MF Marshalkin…
Index: Zhichareva, G. P.; Yakhontov, L. N.; Marshalkin, M. F.; Turchin, K. F.; Kuleshova, E. F.; Sheinker, Yu. N. Pharmaceutical Chemistry Journal, 1991 , vol. 25, # 1 p. 22 - 26 Khimiko-Farmatsevticheskii Zhurnal, 1991 , vol. 25, # 1 p. 32 - 36
Full Text: HTML
Citation Number: 1
Abstract
Introduction of an 8-methyl group into the molecule of 1, 3, 7-trimethylaxanthine (caffeine) provided a pharmaceutical compound [3, 4] which has been used to treat cardiovascular diseases and for a long time has taken the place of caffeine in dry medicinal forms. This has led to the extension of research investigations into a large number of 8-substituted methylxanthines [i, 2, 4, 6]. It has recently been reported in the literature [9] that 8- ...
Related Articles:
Novel quinuclidine-based ligands for the muscarinic cholinergic receptor
[Saunders, John; Cassidy, Mark; Freedman, Stephen B.; Harley, Elizabeth A.; Iversen, Leslie L.; et al. Journal of Medicinal Chemistry, 1990 , vol. 33, # 4 p. 1128 - 1138]